Cargando…
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
BACKGROUND: Approximately 5% to 10% of pancreatic ductal adenocarcinoma (PDAC) has a hereditary basis. In most of these defined hereditary cancer syndromes, PDAC is not the predominant cancer type. Traditional criteria for publicly funded genetic testing typically require the presence of a set combi...
Autores principales: | Cremin, Carol, Howard, Sarah, Le, Lyly, Karsan, Aly, Schaeffer, David F., Renouf, Daniel, Schrader, Kasmintan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842519/ https://www.ncbi.nlm.nih.gov/pubmed/29541281 http://dx.doi.org/10.1186/s13053-018-0088-y |
Ejemplares similares
-
Familial atypical multiple mole melanoma (FAMMM) syndrome: genetic heterogeneity and malignant melanoma.
por: Lynch, H. T., et al.
Publicado: (1980) -
Recurrent melanoma development in a Caucasian female with CDKN2A+ mutation and FAMMM syndrome: A case report
por: Gu, Kaien, et al.
Publicado: (2020) -
Tumour spectrum in the FAMMM syndrome.
por: Lynch, H. T., et al.
Publicado: (1981) -
Systemic cancer and the FAMMM syndrome.
por: Bergman, W., et al.
Publicado: (1990) -
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)